Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in type II diabetes mellitus?

Clinical Science

Volumn 101, Issue 1, 2001, Pages 29-35

  Rustemeijer, C ^a   Schouten, J A ^a   Voerman, H J ^a   Beynen, A C ^a   Donker, A J M ^a   Heine, R J ^a  

^a AMSTELLAND HOSPITAL   (Netherlands)

Author keywords

apoE phenotype; Pseudocholinesterase; Triacylglycerols; Type II diabetes mellitus

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BEZAFIBRATE; CHOLINESTERASE; INSULIN; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN SYNTHESIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS E; BEZAFIBRATE; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INSULIN; LINEAR MODELS; MALE; PHENOTYPE; PRAVASTATIN; PSEUDOCHOLINESTERASE; TRIGLYCERIDES;

EID: 0034942187     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20000280     Document Type: Article

References (30)

1. Biological function of cholinesterase
2. Pseudocholinesterase in obese and hyperlipidaemic subjects
3. Serum pseudocholinesterase and ceruloplasmine in various types of hyperlipoproteinaemia
4. Cholinesterase in serum and low density lipoprotein of hyperlipidaemic patients
5. Pseudocholinesterase/high density lipoprotein cholesterol ratio in serum of normal persons and of hyperlipoproteinemics
6. Levels of serum lipids, apolipoproteins A-1 and B, and pseudocholinesterase activity and their discriminative value in patients with coronary by-pass operation
7. Relationship between serum pseudocholinesterase and triglycerides in experimental induced diabetes mellitus in rats
8. Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensivity in diabetes mellitus
9. Hyperlipidemia in diabetes
10. Lipoprotein receptors and cholesterol homeostasis
11. Apolipoprotein E genetic variants provide insights into its structure and function
12. Normalisation of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation
13. Dietary fat clearance in normal subjects in relation to the apoprotein E phenotype
14. Detection and managements of lipid disorders in diabetes (consensus statement)
15. Mechanism of action of fibrates on lipid and lipoprotein metabolism
16. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia
17. Effects of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men
18. Nutritional recommendations and principles for individuals with diabetes mellitus
19. Cholinesterase (EC 3.1.1.8) mit butyrylthiocholin-iodid als substrat: Referenzwerte in abhängigkeit von alter, geslecht unter berüksichtigung hormonaler einflüsse und swangerschaft
20. Current status of blood cholesterol management in clinical laboratories in the United States: A report from the Laboratory Standardization Panel of the National Cholesterol Education Program
21. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge
22. Measurement of low-density-lipoprotein cholesterol in serum: A status report
23. A rapid micromethod for apolipoprotein E phenotyping directly in serum
24. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
25. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes
26. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia
27. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects
28. Association between apoE alleles, remnant lipoproteins and VLDL subclass phenotypes in the Framingham Offspring Study
29. Pseudocholinesterase and serum lipoproteins